Domů › Rakovina prostaty › Arizona › Scottsdale
Klinické studie Rakovina prostaty v Scottsdale, AZ
17 studií pro Rakovina prostaty hledá účastníky v lokalitách v Scottsdale a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
Radiation Therapy With RapidPlan Knowledge-based Planning vs Human-Driven Planning for Treatment of Prostate Cancer
Probíhá náborFáze 3
- Mayo Clinic in Arizona, Scottsdale
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Probíhá náborFáze 2
- Mayo Clinic in Arizona, Scottsdale
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
Probíhá náborFáze 3
- Mayo Clinic, Scottsdale
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Probíhá náborFáze 3
- Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers, Scottsdale
Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial
Probíhá náborFáze 2
- Mayo Clinic in Arizona, Scottsdale
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Probíhá náborFáze 2/3
- Honor Health Research Institute, Scottsdale
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Probíhá nábor
- Mayo Clinic, Scottsdale
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
Probíhá náborFáze 1
- HonorHealth, Scottsdale
A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer
Probíhá náborFáze 1/2
- Honor Health Research Institute, Scottsdale
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Probíhá náborFáze 1/2
- Honor Health, Scottsdale
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Probíhá náborFáze 2
- HonorHealth Research Institute, Scottsdale
Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients
Probíhá náborRaná fáze 1
- Mayo Clinic in Arizona, Scottsdale
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer
Probíhá náborFáze 1/2
- Honor Health, Scottsdale
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Probíhá náborFáze 4
- Mayo Clinic Arizona, Scottsdale
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Probíhá náborFáze 1
- HonorHealth Research Institute, Scottsdale
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
Probíhá náborFáze 4
- Scottsdale Medical Imaging, LLC, Scottsdale
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Probíhá náborObservační studie
- Massive Bio SYNERGY-AI site, Scottsdale
Studie Rakovina prostaty v jiných městech
- New York City, NY103 studií
- Houston, TX76 studií
- Los Angeles, CA61 studií
- Boston, MA59 studií
- St. Louis, MO46 studií
- Chicago, IL45 studií
- San Francisco, CA45 studií
- Philadelphia, PA44 studií
- Baltimore, MD43 studií
- Nashville, TN43 studií
- Seattle, WA42 studií
- Washington, DC38 studií
Další studie v Scottsdale
- Rakovina prsu18 studií
- Rakovina (všechny typy)18 studií
- Metastatický karcinom17 studií
- Kolorektální karcinom16 studií
- Nemalobuněčný plicní karcinom15 studií
- Rakovina slinivky břišní13 studií
- Melanom10 studií
- Ulcerózní kolitida8 studií
- Rakovina plic8 studií
- Rakovina jater (hepatocelulární karcinom)7 studií
- Alzheimerova choroba7 studií
- Trojně negativní rakovina prsu7 studií
Zdroj: ClinicalTrials.gov, data načtena 6. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.